{
  "id": 9199302,
  "title": "Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change",
  "url": "https://urgent.news/2026/09/22/helus-pharma-announces-results-of-annual-and-special-meeting-of",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-22T21:02:54.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/helus-pharma-announces-results-of-annual-and-special-meeting-of-shareholders-and-effective-date-for-legal-name-change"
  },
  "original_language": "en",
  "account": null,
  "summary": "TORONTO, Sept. 22, 2026 (GLOBE NEWSWIRE) — Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (“Helus” or the “Company”), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), is pleased to announce the voting results for each of the matters presented at the Company’s annual and special meeting of shareholders […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Helus Pharma shareholders approve name change from Cybin Inc.",
        "url": "https://urgent.news/2026/09/22/helus-pharma-shareholders-approve-name-change-from-cybin-inc",
        "published": "2026-09-22T21:04:32.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}